APOF and cervical cancer: By validating the hub proteins using the ELISA, the authors introduced ORM1 (Orosomucoid 1) and APOF (Apolipoprotein F) as novel potential plasma markers in high grade squamous intraepithelial lesion (HSIL) and cervical cancer (49).